The Alternative Splicing of ApoER 2 in Alzheimer ’ s Disease

Over five million adults over the age of 65 currently suffer from Alzheimer’s disease (AD), a debilitating disease with no cure. Early diagnosis of AD allows for an increased ability to manage the disease, but diagnosis is limited by a lack of reliable AD biomarkers. While there is no singular cause, research has linked an isoform of ApoE to early onset AD, but recently more attention has been placed upon one of ApoE’s receptors, ApoER2. Like most genes, ApoER2 undergoes multiple alternative splicing events to create distinct mRNA isoforms. One Splicing event, exon 18 inclusion vs. skipping, creates two isoforms with opposing functions in reelin signaling, synaptic plasticity, and memory functions. We hypothesize that ApoER2 alternative splicing correlates with AD progression. Using cellular and animal models, and human samples, we found a disease state association between increasing AD severity and increased ApoER2 exon 18 skipping. We conclude that ApoER2 may play a role in regulating a pathway that is deregulated in AD. Acknowledgements This thesis would not have been possible without the support of a handful of individuals. First, I would like to thank Dr. Michelle Hastings for the opportunity to work in her lab; her mentorship throughout this process proved indispensable. I would also like to acknowledge Dr. Shubhik DebBurman for his never-ending support and guidance throughout not only this process but my entire experience at Lake Forest College. Thank you for constantly pushing me to achieve more than I knew I was capable of. Additionally, I would like to thank Professor Dawn AbtPerkins and Dr. Robert Glassman for working with me on a rushed time table to make this thesis possible. My research would not have been possible without those who previously worked on this project, including: Paige, Angela, etc. The support and guidance of Fran Jodelka, Mallory Havens, Alicia Case, Anthony Hinrich, Cidi Wee, Ashley Reich, Kate McCaffrey, and Alejandra Luna also allowed me to learn more than I could have hoped, and their ability to put up with my never-ending questions still astounds me. Lastly, I would like to thank those that have supported me throughout not only this endeavor by my entire life as well, my family. Without their support I would never have been able to get to this point in my life. I also need to thank my peers in the biology and neuroscience departments for helping me throughout the past few years and my friends in Delta Gamma Fraternity for their constant affection and ability to make sure I kept my sanity as I pushed myself to complete this capstone in my education.

[1]  M. Weiner,et al.  The dynamics of cortical and hippocampal atrophy in Alzheimer disease. , 2011, Archives of neurology.

[2]  Ruth Williams,et al.  Biomarkers: Warning signs , 2011, Nature.

[3]  Alzheimer’s Association,et al.  2011 Alzheimer’s disease facts and figures , 2011, Alzheimer's & Dementia.

[4]  Karl Herrup,et al.  Reimagining Alzheimer's Disease—An Age-Based Hypothesis , 2010, The Journal of Neuroscience.

[5]  C. Lippa,et al.  Review: Disruption of the Postsynaptic Density in Alzheimer’s Disease and Other Neurodegenerative Dementias , 2010, American journal of Alzheimer's disease and other dementias.

[6]  Xiongwei Zhu,et al.  Mitochondrial biology in Alzheimer’s disease pathogenesis , 2010, Journal of neurochemistry.

[7]  M. Pleckaityte,et al.  [Alzheimer's disease: a molecular mechanism, new hypotheses, and therapeutic strategies]. , 2010, Medicina.

[8]  V. Hachinski,et al.  Changing perspectives regarding late-life dementia , 2009, Nature Reviews Neurology.

[9]  F. Schmitt,et al.  Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain , 2009, Molecular Neurodegeneration.

[10]  C. White,et al.  Reelin signaling antagonizes β-amyloid at the synapse , 2009, Proceedings of the National Academy of Sciences.

[11]  Frederico A. C. Azevedo,et al.  Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled‐up primate brain , 2009, The Journal of comparative neurology.

[12]  A. Baba,et al.  Splicing variations in the ligand-binding domain of ApoER2 results in functional differences in the binding properties to Reelin , 2009, Neuroscience Research.

[13]  R. Mayeux,et al.  Memory performance is related to amyloid and tau pathology in the hippocampus , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[14]  G. D’Arcangelo,et al.  The Reelin Signaling Pathway Promotes Dendritic Spine Development in Hippocampal Neurons , 2008, The Journal of Neuroscience.

[15]  J. Takagi,et al.  Structure of a receptor-binding fragment of reelin and mutational analysis reveal a recognition mechanism similar to endocytic receptors , 2007, Proceedings of the National Academy of Sciences.

[16]  D. Selkoe,et al.  Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.

[17]  J. Herz,et al.  Reelin, lipoprotein receptors and synaptic plasticity , 2006, Nature Reviews Neuroscience.

[18]  W. Schneider,et al.  Reconstitution of the Reelin Signaling Pathway in Fibroblasts Demonstrates that Dab1 Phosphorylation Is Independent of Receptor Localization in Lipid Rafts , 2006, Molecular and Cellular Biology.

[19]  M. Frotscher,et al.  Modulation of Synaptic Plasticity and Memory by Reelin Involves Differential Splicing of the Lipoprotein Receptor Apoer2 , 2005, Neuron.

[20]  B. Hyman,et al.  The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor Published, JLR Papers in Press, May 1, 2005. DOI 10.1194/jlr.M500114-JLR200 , 2005, Journal of Lipid Research.

[21]  E. Weeber,et al.  Reelin, Very-Low-Density Lipoprotein Receptor, and Apolipoprotein E Receptor 2 Control Somatic NMDA Receptor Composition during Hippocampal Maturation In Vitro , 2005, The Journal of Neuroscience.

[22]  G. Gamkrelidze,et al.  ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-β1–42 , 2005, Neurobiology of Disease.

[23]  J. Richardson,et al.  Cognitive correlates of Aβ deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes , 2004, Brain Research.

[24]  David A. Bennett,et al.  Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer’s disease , 2004, Neurobiology of Aging.

[25]  B. Zlokovic Clearing amyloid through the blood–brain barrier , 2004, Journal of neurochemistry.

[26]  D. Bennett,et al.  Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.

[27]  L. Murri,et al.  Causative and susceptibility genes for Alzheimer’s disease: a review , 2003, Brain Research Bulletin.

[28]  A. Goffinet,et al.  Reelin and brain development , 2003, Nature Reviews Neuroscience.

[29]  J. Woo,et al.  Low-density lipoprotein receptor-related protein 8 (apolipoprotein E receptor 2) gene polymorphisms in Alzheimer's disease , 2002, Neuroscience Letters.

[30]  J. Sweatt,et al.  Reelin and ApoE Receptors Cooperate to Enhance Hippocampal Synaptic Plasticity and Learning* , 2002, The Journal of Biological Chemistry.

[31]  S. Liebhaber,et al.  Targeting a KH-domain protein with RNA decoys. , 2002, RNA.

[32]  B. Oken Practice parameter: Management of dementia (an evidence-based review) , 2001, Neurology.

[33]  Yasuhiro Nakamura,et al.  Significance of the variant and full-length forms of the very low density lipoprotein receptor in brain , 2001, Brain Research.

[34]  A. Krainer,et al.  Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. , 2001, Molecular cell.

[35]  M. Sheng,et al.  Dentritic spines : structure, dynamics and regulation , 2001, Nature Reviews Neuroscience.

[36]  W. Schneider,et al.  Alternative Splicing in the Ligand Binding Domain of Mouse ApoE Receptor-2 Produces Receptor Variants Binding Reelin but Not α2-Macroglobulin* , 2001, The Journal of Biological Chemistry.

[37]  E. Wagner,et al.  Polypyrimidine Tract Binding Protein Antagonizes Exon Definition , 2001, Molecular and Cellular Biology.

[38]  B. Graveley Sorting out the complexity of SR protein functions. , 2000, RNA.

[39]  W. Schneider,et al.  The Reelin Receptor ApoER2 Recruits JNK-interacting Proteins-1 and -2* , 2000, The Journal of Biological Chemistry.

[40]  Joachim Herz,et al.  Direct Binding of Reelin to VLDL Receptor and ApoE Receptor 2 Induces Tyrosine Phosphorylation of Disabled-1 and Modulates Tau Phosphorylation , 1999, Neuron.

[41]  N. Shen,et al.  Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis , 1999, Nature Genetics.

[42]  Jonathan A. Cooper,et al.  Reelin-induced tryosine phosphorylation of Disabled 1 during neuronal positioning , 1999 .

[43]  J. Nevins,et al.  Inhibition of cell proliferation by an RNA ligand that selectively blocks E2F function , 1996, Nature Medicine.

[44]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[45]  B. Hyman,et al.  Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.

[46]  C. Cotman,et al.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[48]  Paul D. Coleman,et al.  Neuron numbers and dendritic extent in normal aging and Alzheimer's disease , 1987, Neurobiology of Aging.

[49]  R. Glockshuber,et al.  Amyloid-beta aggregation. , 2007, Neuro-degenerative diseases.

[50]  Molecular Neurodegeneration BioMed Central Review The generation and function of soluble apoE receptors in the CNS , 2006 .

[51]  S. Wiebe,et al.  Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons , 2003 .

[52]  J. Hardy,et al.  Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes , 1998, Nature Medicine.

[53]  Weiming Xia,et al.  Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice , 1997, Nature Medicine.

[54]  D. Selkoe Alzheimer's disease: genotypes, phenotypes, and treatments. , 1997, Science.

[55]  J. Ma,et al.  Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. , 1994, Nature.

[56]  A. Alzheimer Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .